The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SAR SAREUM HOLDINGS PLC ORD 0.025P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
10:56 05-Nov-2019 SAR Sareum notes Sierra Oncology Q3 2019 results RNS +1.17% Up
07:00 30-Oct-2019 SAR Research Update - SDC-1802 anti-cancer poster RNS +2.37% Up
07:00 17-Oct-2019 SAR Research Update - AACR-NCI-EORTC abstract RNS +3.64% Up
07:00 15-Oct-2019 SAR Final Results RNS -4.34% Down
07:00 07-Oct-2019 SAR Notice of Full Year Results RNS -7.37% Down
07:00 27-Sep-2019 SAR Research Update - TYK2/JAK1 cancer programme RNS +23.15% Up
07:00 27-Aug-2019 SAR Trading Statement RNS -4.57% Down
07:00 16-Aug-2019 SAR Change of Adviser RNS +9.97% Up
14:17 08-Aug-2019 SAR Sareum notes Sierra Q2 results RNS -21.37% Down
16:29 29-Jul-2019 SAR Additional disclosure concerning Michael Owen RNS +5.61% Up
07:00 28-Jun-2019 SAR Additional Funds Raised RNS -13.07% Down
13:50 27-Jun-2019 SAR Sierra seeks strategic options for SRA737 RNS -17.55% Down
07:00 26-Jun-2019 SAR Successful Fundraising RNS -21.27% Down
16:31 25-Jun-2019 SAR PrimaryBid.com Offer RNS -16.70% Down
16:30 25-Jun-2019 SAR Placing to progress TYK2/JAK1 programmes RNS -16.70% Down
07:00 13-Jun-2019 SAR Portfolio Update RNS -3.46% Down
16:00 03-Jun-2019 SAR Key takeaways from SRA737 webcast at ASCO RNS -4.10% Down
11:05 03-Jun-2019 SAR Second Price Monitoring Extn RNS -4.10% Down
11:00 03-Jun-2019 SAR Price Monitoring Extension RNS -4.10% Down
07:00 03-Jun-2019 SAR Positive SRA737 data presented at ASCO RNS -4.10% Down

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Company Information
Company website http://www.sareum.co.uk
Company address Unit 2a, Langford Arch, London Road, Pampisford, Cambridge, CB22 3FX, United Kingdom
FTSE ICB sector Pharmaceuticals, Biotechnology and Marijuana Producers
FTSE ICB subsector Pharmaceuticals
Company market cap, £m* 10.44
Admission date 11 Oct 2004
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.


Security Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
Market AIM
Market identifier code (MIC) AIMX
Trading service SETSqx
Trading segment ASX1
Listing category -
Country of share register GB
ISIN GB00B02RFS12
SEDOL B02RFS1
Exchange market size 300,000
Security market cap, £m 10.44
*The market capitalisation of the security reflects data from previous trading day.


SAREUM share news analysis (SAR)